TRAF6 is a signal transducer that activates IκB kinase (IKK) and Jun amino-terminal kinase (JNK)
in response to pro-inflammatory mediators such as interleukin-1 (IL-1) and …

However, this information was from what now appears to be first-generation cases from a point
source, but at the time it seems that a second generation, and perhaps a third generation, …

Background Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus
disease (COVID-19) were based on information from the general population. Limited …

Background No specific antiviral drug has been proven effective for treatment of patients
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …

Rationale: The prevalence of chronic obstructive pulmonary disease (COPD) in China is
largely unknown. Objectives: To obtain the COPD prevalence in China through a large-…

Fangcang shelter hospitals are a novel public health concept. They were implemented for
the first time in China in February, 2020, to tackle the coronavirus disease 2019 (COVID-19) …

Background No therapeutics have yet been proven effective for the treatment of severe
illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label …

TRAF6 is a signal transducer in the NF-κB pathway that activates IκB kinase (IKK) in response
to proinflammatory cytokines. We have purified a heterodimeric protein complex that links …

Two-dimensional layered semiconductors such as MoS 2 and WSe 2 have attracted considerable
interest in recent times. Exploring the full potential of these layered materials requires …

Background The long-term health consequences of COVID-19 remain largely unclear. The
aim of this study was to describe the long-term health consequences of patients with COVID-…